BioIntervene

BioIntervene, Inc. is a preclinical-stage biopharmaceutical company dedicated to the discovery and development of effective and non-addictive drugs for treating chronic pain, other chronic inflammatory conditions, and neurodegenerative diseases. The founding team of BioIntervene has pioneered the understanding of adenosine A3 receptor biology, focusing on the development of first-in-class selective adenosine A3 receptor agonists.